Nguyen HT et al. |
Molecular characterization of Glycine max squalene synthase genes in seed phytosterol biosynthesis. |
2013 |
Plant Physiol. Biochem. |
pmid:24036394
|
Borchman D et al. |
Confirmation of the presence of squalene in human eyelid lipid by heteronuclear single quantum correlation spectroscopy. |
2013 |
Lipids |
pmid:24081494
|
Rajaram K et al. |
Comparative bioactive studies between wild plant and callus culture of Tephrosia tinctoria pers. |
2013 |
Appl. Biochem. Biotechnol. |
pmid:24026411
|
Villa M et al. |
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. |
2013 |
Am. J. Epidemiol. |
pmid:23863759
|
Robinson ES et al. |
Organic aerosol mixing observed by single-particle mass spectrometry. |
2013 |
J Phys Chem A |
pmid:24131283
|
Rouleau I et al. |
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. |
2013 |
Vaccine |
pmid:24144473
|
Vono M et al. |
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24324152
|
Pannkuk EL et al. |
Sebaceous lipid profiling of bat integumentary tissues: quantitative analysis of free Fatty acids, monoacylglycerides, squalene, and sterols. |
2013 |
Chem. Biodivers. |
pmid:24327437
|
Tegenge MA and Mitkus RJ |
A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines. |
2013 |
J Pharmacokinet Pharmacodyn |
pmid:23912214
|
Trung Bui D et al. |
Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy. |
2013 |
Biomacromolecules |
pmid:23829862
|
Bruun Laursen A |
[Catastrophic consequences of Pandemrix swine flu vaccine containing squalene]. |
2013 |
Ugeskr. Laeg. |
pmid:23833781
|
Mølbak K |
[Squalene unlikely sinner]. |
2013 |
Ugeskr. Laeg. |
pmid:23833782
|
Gefenaite G et al. |
Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination. |
2013 |
PLoS ONE |
pmid:23840413
|
Fox CB and Haensler J |
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. |
2013 |
Expert Rev Vaccines |
pmid:23885820
|
Sisco E et al. |
Evaluation of C60 secondary ion mass spectrometry for the chemical analysis and imaging of fingerprints. |
2013 |
Forensic Sci. Int. |
pmid:23890648
|
King KL et al. |
Inelastic scattering of OH radicals from organic liquids: isolating the thermal desorption channel. |
2013 |
Phys Chem Chem Phys |
pmid:23807737
|
Chandramouli S et al. |
Generation of a parvovirus B19 vaccine candidate. |
2013 |
Vaccine |
pmid:23827313
|
Durier C et al. |
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults. |
2013 |
AIDS |
pmid:23018437
|
Lin YK et al. |
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. |
2013 |
Pharm. Res. |
pmid:23070602
|
Lopez P et al. |
Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule. |
2013 |
Clin. Vaccine Immunol. |
pmid:23536690
|